Page last updated: 2024-08-24

plerixafor and cabozantinib

plerixafor has been researched along with cabozantinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asara, JM; Avigan, DE; Balk, SP; Cantley, LC; Clohessy, JG; Csizmadia, E; Elemento, O; Gehring, MP; Helenius, K; Karp, JM; Kelly, K; Landon-Brace, N; Levantini, E; Montaser, L; Morgan, TM; Novak, J; Olson, BM; Pandolfi, PP; Patnaik, A; Pyzer, AR; Rosenblatt, JM; Signoretti, S; Solanki, A; Swanson, KD; Thornley, TB; Timmons, JJ; Wang, LC; Wang, Y; Ye, H	1

Other Studies

1 other study(ies) available for plerixafor and cabozantinib

Article	Year
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity. Cancer discovery, 2017, Volume: 7, Issue:7 Topics: Anilides; Animals; Benzylamines; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; HMGB1 Protein; Humans; Immunity, Innate; Male; Mice; Neutrophils; Prostatic Neoplasms; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Pyridines; Tumor Microenvironment; Tumor Suppressor Protein p53	2017

Article

Year

Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.

Cancer discovery, 2017, Volume: 7, Issue:7

Topics: Anilides; Animals; Benzylamines; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; HMGB1 Protein; Humans; Immunity, Innate; Male; Mice; Neutrophils; Prostatic Neoplasms; Protein Kinase Inhibitors; PTEN Phosphohydrolase; Pyridines; Tumor Microenvironment; Tumor Suppressor Protein p53

2017